The prospect of creating life in the laboratory is as fascinating as it is terrifying. Will we really be able to modify the genetic code of a living creature to mold it to our design? Will we be able to assemble different bits of living creatures to create a new one?
A few years back, J. Craig Venter announced the creation of a living, self-reproducing bacterial cell with a DNA sequence produced in the laboratory. According to Laurie Garretts 2013 article for Foreign Affairs about this experiment, the creature moved, ate, breathed, and replicated itself. Garrett quotes from an older interview with Venter from 2009: Theres not a single aspect of human life that doesnt have the potential to be totally transformed by these technologies in the future.
These technologies refer to the world of synthetic biology, the ability to construct living creatures from the assembly of different parts in a sort of Lego world of the living. Playing the game of life is no longer the stuff of sci-fi stories. If you need further proof, I refer you to the Big Think video featuring Nobel Prize-winner Jennifer Doudna (as well as a recent interview), exploring the universe of CRISPR technology the good and the bad of it. Also, check out the excellent Netflix documentary series Unnatural Selection.
The question, as this technology evolves, becomes one of regulation and control. As Richard Lewontin asked in his essay on synthetic biology for The New York Review of Books, In cases where there is a conflict between the immediate and the long-range consequences or between the public and private good, how can that conflict be resolved?
The difference between the gothic speculations of Mary Shelleys Frankenstein and todays reality is twofold: First, we are building these creatures fiction is now real. Second, money plays a huge role in it. There is great financial gain in genetic engineering, an industry that according to estimates offered by Drew Endy from Stanford Universitys bioengineering department, contributes two percent of the U.S. economy and is growing at a pace of 12 percent each year.
The problem, as Lewontin reminds us, is that we often cannot rely on those who pursue invention for profit or for military interests to have the publics best interest in mind. So, as we create new lifeforms for different purposes, who will control them? The stockholders of biotech companies? The government? How will we reach a consensus on such a divisive topic that has clear global reach?
Subscribe for counterintuitive, surprising, and impactful stories delivered to your inbox every Thursday
The stakes are so high, and discussion must be brought into the open. There are great possibilities and great dangers. There is money to be made and cures to be found. There are horrible weapons and potential environmental chaos, too. The biosphere is a complex network of unpredictable interactions and responses that affect us and every other voiceless creature on this planet. Collectively as the human species, we must have some control over where all this is going. But how?
The opinions of scientists matter, of course. Corporate accountability and manufacturer liability are certainly reasonable. And there also should be democratic participation and transparency. We are all stakeholders in this debate.
All sorts of questions come into the open, questions that we should already be thinking about very seriously. Years have passed since this started, and there hasnt been much progress on addressing those questions. Synthetic creations such as genetically modified organisms (GMOs) are widely available, and a growing number of people are eating them. As far as science is concerned, there is no reason for us not to. (It is telling that so much conflict goes into the commercial labeling of such products, so that people actually know what they are consuming.)
How could we enforce the full public participation? How can we guarantee that different sectors of the population in this and other countries know enough about the various issues to reach a well-informed opinion? Some of the issues involved are extremely technical, and even the experts disagree on the details, as is the case with most cutting-edge research. How can we guarantee that government legislators are free of party bias or lobbying influences as they decide how to rule on the matter? Will the health and social benefits from the technology outpace its potential dangers?
Governments will face internal conflict, as they need to protect their citizens, defending them from any enemy that might use synthetic bioweapons. They may, of course, manufacture the weapons as well, perhaps mirroring the nuclear dtente policy of Mutually Assured Destruction: If you attack me, I attack you, and we both die. Very safe policy indeed, and very morally advanced.
If such technologies are used in wars or terrorist attacks, how efficiently will we be able to isolate from them? Judging from the responses to the COVID pandemic, government efficiency leaves much to be desired. Unless you plant your own organic garden and live in some sort of ecologically insulated bubble, synthetic biology will be knocking at your door. The question, then, is whether it will usher in a new era for humanity, or end up as the latest example of a promising technology that is used to inflict pain and destruction. Such technologies have emerged from physics (nuclear bombs) and from chemistry (poison gas). Now that its biologys turn, hopefully our past experiences have made us wiser.Hopefully we know better, now.
Read the original post:
Synthetic biology has the power to cure and kill. How will we use it? - Big Think
- Principles of Genetic Engineering - PMC - National Center for ... - March 28th, 2024
- Historic Overview of Genetic Engineering Technologies for Human Gene ... - March 28th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - December 10th, 2023
- Genetically modified organism - Wikipedia - November 16th, 2023
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - November 16th, 2023
- 18 Human Genetic Engineering - Clemson University - April 7th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - April 7th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 12th, 2023
- Genetic Engineering Principles of Biology - December 27th, 2022
- Engineering the Perfect Baby | MIT Technology Review - December 27th, 2022
- What is CRISPR? | Live Science - November 24th, 2022
- To modify or not to modify? Genetic Modification and Gene Editing - A divergence by the UK - Lexology - October 13th, 2022
- DNA and the impossibility of research in isolation - Morning Star Online - October 13th, 2022
- Genome editing technologies: final conclusions of the re-examination of Article 13 of the Oviedo Convention - Council of Europe - October 13th, 2022
- Approval, Commercialization Highlighted at Cell & Gene Meeting on the Mesa - Genetic Engineering & Biotechnology News - October 13th, 2022
- Dissatisfaction and New Articulations - Discovery Institute - October 13th, 2022
- In 'The Cultivar Series,' Uli Westphal Gets to the Root of Crop Diversity and Agricultural Modification - Colossal - October 13th, 2022
- Genomic Research Aids in the Effort to Understand How Best to Treat Deadly Infections Caused by a Fungus - UMass News and Media Relations - October 13th, 2022
- Synthetic Biology Market is Expected to Report a CAGR of ~21% from 2021 to 2029: Industry Size, Growth & Forecast at Douglas Insights - Yahoo... - October 13th, 2022
- Farmers, consumers will embrace GMOs if they understand them - The Standard - October 13th, 2022
- Emily Whitten: The limits of science and human intelligence - WORLD News Group - October 13th, 2022
- Behind this Nobel prize is a very human story: theres a bit of Neanderthal in all of us - The Guardian - October 13th, 2022
- Earth materials in technology The National - The National - October 13th, 2022
- Gene therapy brings hope to people with sickle cell, HIV - Monitor - October 13th, 2022
- Eligo Bioscience Receives FDA Orphan Drug Designation (ODD) and Rare Pediatric Disease (RPD) Designation for EB003 for the Prevention of Hemolytic... - October 13th, 2022
- Skin Grafting, Cryopreservation, and Diseases: A Review Article - Cureus - October 13th, 2022
- Cultured meat could help solve the climate crisis. Heres what it will take to move it from the lab to the dinner table - Fortune - October 13th, 2022
- Ignore scary messages: We've never had it so good & that's not manure - West Side Index & Gustine Press-Standard - October 13th, 2022
- Global Phosphoramidite Market Report 2022: Increasing Synthetic Nucleotide Applications in Therapeutics Drives Growth - ResearchAndMarkets.com -... - October 13th, 2022
- Enzymes Market worth $16.9 billion by 2027 - Exclusive Report by MarketsandMarkets - Yahoo Finance - October 4th, 2022
- Experts Sound Alarm Over 'Growing Threat' of Genetically Engineered Trees - Common Dreams - October 4th, 2022
- Scientists are manipulating the DNA of mosquitoes to fight the spread of malaria - Euronews - October 4th, 2022
- Smile Coffee Werks upgraded its coffee beans to Fair Trade and USDA Organic - Vending Market Watch - October 4th, 2022
- COVID mRNA Jabs and Testing Kicked Off This Industry of Drug Development: Here's What You Need to Know - The Epoch Times - October 4th, 2022
- 22nd Century Group (Nasdaq: XXII) Expands VLN Distributor Network with the Addition of Specialty Distrib - Benzinga - October 4th, 2022
- Researchers are seeking to develop spuds that resist harmful nematodes - FreshPlaza.com - October 4th, 2022
- SPECIAL REPORT: Bioengineered food labeling: 'They kind of shot in the middle and missed every constituency' - FoodNavigator-USA.com - September 25th, 2022
- Yeast-Fermented Chemo: Now We Can Brew Anything - Medscape - September 25th, 2022
- September 23, 2022: The Integrity of Marius Mason WFHB - WFHB News - September 25th, 2022
- 2 Risky Cathie Wood Growth Stocks to Buy and Hold for 5 Years - The Motley Fool - September 25th, 2022
- Bananas threatened by devastating fungus given temporary resistance - New Scientist - September 25th, 2022
- 'What Hath God Wrought' - Today, Luddites Are Concerned About Weedkillers Like They Once Were The Telegraph - Science 2.0 - September 25th, 2022
- Children should be educated about oral health and hygiene - Star of Mysore - September 25th, 2022
- Id rather eat an actual burger: why plant-based meats sizzle fizzled in the US - The Guardian - September 25th, 2022
- Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals - Fortune - September 25th, 2022
- Last Chance This Fall to Tell the NOSB To Uphold Organic Integrity - Beyond Pesticides - September 25th, 2022
- Cambodian PM begins official visit to Cuba - Khmer Times - September 25th, 2022
- Researchers develop method to prevent spread of melanoma to brain - Xinhua - September 25th, 2022
- I'm allergic to the cat, what can I do? - Surinenglish.com - September 25th, 2022
- Researchers Propose a New Way of Regulating Engineered Crops - Modern Farmer - September 16th, 2022
- Purple Tomato is first genetically engineered plant to be deregulated through USDA's new regulatory status review process - Lexology - September 16th, 2022
- Genetically Modified Feed Market to Hit $135 billion by 2030, says Global Market Insights Inc. - Yahoo Finance - September 16th, 2022
- Africa, GMOs and Western Interests - DW (English) - September 16th, 2022
- The science behind the oil supply breakdown in 'Last Light' - Syfy - September 16th, 2022
- Inside the controversial plan to bring extinct animals back from the dead - The Independent - September 16th, 2022
- Star Trek Actor Says Their Trek Hero Is Just Like Their Marvel Character - Giant Freakin Robot - September 16th, 2022
- Scientists closer to making blood stem cells in the lab - Cosmos - September 16th, 2022
- Oncolytic Cancer Therapies Market is expected to grow at a CAGR of 33% by 2032 | DelveInsight - Digital Journal - September 16th, 2022
- Don't call it waste - it can be turned into hydrogen if you handle it right - Innovation Origins - September 16th, 2022
- Can gene editing ease the cost of living crisis? - The Grocer - September 8th, 2022
- Gene editing could revive the American chestnut tree and help fight climate change but familiar anti-biotechonology activist critics will have none... - September 8th, 2022
- Colossal to de-extinct the Tasmanian tiger. Is it a safe thing to do? - Cape Cod Times - September 8th, 2022
- The Future of Nanotech, the World's Tiniest Industry - Entrepreneur - September 8th, 2022
- Viewpoint: The 'natural food' sham 'Effective communication on the ethics of science may be hindered by appeals to naturalness' - Genetic Literacy... - September 8th, 2022
- Toray says it has developed the worlds first 100% bio-based adipic acid - Biofuels Digest - September 8th, 2022
- Chinese scientists claim to have engineered the world's first mouse with fully reprogrammed genes - Interesting Engineering - August 30th, 2022
- Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to... - August 30th, 2022
- Living Carbon: The startup setting down roots from 9 to 5 | Greenbiz - GreenBiz - August 30th, 2022
- Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through... - August 30th, 2022
- Genetics in fiction - Wikipedia - August 14th, 2022
- Weeds superpower could help feed the planet - Freethink - August 14th, 2022
- POSEIDA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - August 14th, 2022
- Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma - Genetic Engineering & Biotechnology News - August 14th, 2022
- LETTER TO THE EDITOR: Lessons from 1984 | Letters To Editor | carolinacoastonline.com - Carolinacoastonline - August 14th, 2022
- How Arkeon Biotechnologies is turning CO2 into food: 'Excuse my language, but this is next-level cool' - FoodNavigator.com - August 14th, 2022
- Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks - PR Newswire - August 14th, 2022
- THE SAD STORY OF THE REJECTION OF SCIENCE - Sp Supplements - DAWN.COM - DAWN.com - August 14th, 2022
- Global Genome Editing Technologies market is projected to grow at a CAGR of 15.96% by 2032: Visiongain Reports Ltd - Yahoo Finance - August 5th, 2022
- I Got Critiqued by YouTuber Gutsick Gibbon - Discovery Institute - August 5th, 2022
- CRISPR Technology in the Agricultural Industry: Patent and Regulatory Updates - JD Supra - August 5th, 2022